AzTrials
AzTrials

Hemispatial NeglectNCT02945592

Active Cue-Training in Neglect

A study testing Cueing in people with Hemispatial Neglect, run by Klinikum Bremen Ost at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The presented study investigates standardized visual cueing in reading and visual spatial task as a treatment method for spatial neglect. In a randomized controlled design patients receive either cued reading and visual spatial tasks (intervention) or treatment which is unspecific to neglect (control). Read more about this study

Who is it for?
Any age
Conditions the study is for
Hemispatial Neglect
What is being tested?
Cueing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteGermany
Study dates
Oct 2016to Jan 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Left sided neglect
  • Capacity of at least 30 minutes
  • Ability to read in German language
  • Mobilization of 80%

Who cannot join

  • Previous known dementia
  • Normal pressure hydrocephalus
  • Exclusion Criteria for tDCS Add-on (not exclusion of the intervention):
  • Shunt
  • Craniectomy
  • Epilepsy
  • Other metal implants

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Klinikum Bremen-Ost

    Bremen, 28325

Other trials in Germany

About this study

The presented study investigates standardized visual cueing in reading and visual spatial task as a treatment method for spatial neglect. In a randomized controlled design patients receive either cued reading and visual spatial tasks (intervention) or treatment which is unspecific to neglect (control).

In the intervention condition, patients with left-sided neglect receive intense training, including reading and visual spatial task with standardized and adapted visual cueing by the therapist. Improvements in reading and visual spatial tasks lead to a reduction of cues by the therapist. Accordingly, the patient has to apply self-cueing over time in order to solve the task.

Read more

For the control condition, all patients receive unspecific treatment without any standardized adapted cueing implemented by the therapist.

To enhance the effectivity of cueing in reading and visual spatial tasks, the investigators additionally conduct parietal transcranial direct current stimulation (tDCS) in those patients without tDCS exclusion criteria (see exclusion criteria below).

It is hypothesised that systematic and adaptive therapeutic cueing leads to a significant reduction of omissions of word and word parts in reading.

UPDATE: No Add-on tDCS was performed since it was not applicable for our severly impaired patients due to the strict exclusion criteria of tDCS.

Being tested
Cueing
Keywords
Hemispatial Neglect, cueing, egocentric-allocentric, early rehabilitation, parietal tDCS
Medical subject headings
Perceptual Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CueingBehavioural

Study groups in NCT02945592
Study groupRoleWhat they receive
InterventionExperimental* adaptive, therapeutic cueing during reading tasks * adaptive, therapeutic cueing during visuo spatial tasks
Receives: Behavioral: Cueing
ControlNo intervention- unspecific neglect treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in word and word-part omissions in standardized reading of text and word list

    the patient has to read a standardized text of 55 words and a word list of 13 words. Omissions of the complete word and/or of a word part are counted.

    Measured: Primary Outcome Measure is assessed two times in the first week (3 days in between), after week 4, after week 7, after week 8

Secondary outcomes (3)
  1. Change in standardized evaluation of the body posture

    A blinded neurologist evaluates spontaneous and cued body posture (head, eyes, trunk) for ipsilesional, moderate ipsilesional or no deviation.

    Measured: Secondary Outcome Measure is assessed two times in the first week (3 days in between), after week 4, after week 7, after week 8

  2. Change in Apples Cancellation Task

    a standardized measurement for the evaluation of egocentric and allocentric neglect symptoms

    Measured: Secondary Outcome Measure is assessed two times in the first week (3 days in between), after week 4, after week 7, after week 8

  3. Change in activities of daily living using the Catherine Bergego Scale

    The blinded hospital staff evaluates activities of daily living by using the Catherine Bergego scale with specified scoring criteria

    Measured: Secondary Outcome Measure is assessed after week 1, after week 4, after week 7, after week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2016 (estimated)
  2. Study startOct 2016
  3. Primary completionNov 2017
  4. Study completionJan 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02945592
Sponsor's protocol ID
367915
Status last verified
Mar 2018
First submitted
19 Oct 2016
Last updated
6 Mar 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Cueing in people with Hemispatial Neglect, run by Klinikum Bremen Ost at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in word and word-part omissions in standardized reading of text and word list (time frame: Primary Outcome Measure is assessed two times in the first week (3 days in between), after week 4, after week 7, after week 8). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in